People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

57.72USD
26 Dec 2014
Price Change (% chg)

$1.56 (+2.78%)
Prev Close
$56.16
Open
$56.21
Day's High
$57.79
Day's Low
$56.17
Volume
330,806
Avg. Vol
842,118
52-wk High
$59.69
52-wk Low
$38.49

Search Stocks

Cooke, Shane 

Brief Biography

Mr. Shane Cooke is President of Alkermes Plc. He is employed by Alkermes Pharma Ireland Limited, an Irish subsidiary of the Company. From May 2005 to September 16, 2011, Mr. Cooke served as a Director of Elan Corporation, plc ("Elan"). From May 2007 to September 16, 2011, Mr. Cooke was Executive Vice President of Elan and Head of EDT. Mr. Cooke served as the Chief Financial Officer of Elan from July 2001, when he joined Elan, until May 2011. Prior to joining Elan, Mr. Cooke was Chief Executive of Pembroke Capital Limited, an aviation leasing company, and prior to that, held a number of senior positions in finance in the banking and aviation industries. He is a chartered accountant. He is currently on the board of directors of Prothena Corporation plc, a publicly traded biotechnology company, and Onclave, a privately held company.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
456,828 -- 2,679,710 3,912,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

8,696,650

Shane Cooke

3,912,100

James Frates

2,095,130

Gordon Pugh

1,965,720

Kathryn Biberstein

2,488,720

Rebecca Peterson

--
As Of 30 Mar 2014
Search Stocks